Natera awarded national MRD testing contract by U.S. Department of Veterans Affairs

Natera was awarded a nationwide contract by the U.S. Department of Veterans Affairs National Precision Oncology Program to provide minimal residual disease testing services using its Signatera test. The contract is effective September 15, 2022.

“We are proud to partner with the VA to make Signatera accessible to our nation's veterans.”prnewswire.com

• 1 source
• prnewswire.comNatera Awarded National MRD Testing Contract by the U.S. Department of Veterans AffairsNatera, Inc.Nov 2, 2022

Summarized from public sources; check the original articles before acting on it.